The results of the first systematic program monitoring the quality of medical care provided to Medicare beneficiaries have been published in the Journal of the American Medical Association.
The results of the first systematic program monitoring the quality of medical care provided to Medicare beneficiaries have been published in the Journal of the American Medical Association (vol. 284, no. 13). The national study evaluated data collected from 1997 through 1999 on all Medicare fee-for-service beneficiaries or a representative sample of individuals with a specific condition. Results varied across all states and measures. Less-populated states and states in the Northeast consistently ranked high in relative performance, while states with higher concentrations and those in the Southeast consistently ranked low.
"The differences in average performance among states and regions are modest compared with the overall need for improvement," wrote the authors. "Nevertheless, the data suggest real underlying geographic differences in the way care is delivered to the Medicare FFS population. They also suggest that variations among states on individual measures are part of a larger pattern and not simply local variations."
Added the authors, "We do not yet understand the reasons for these differences or whether aspects of the systems in high-performing states can be easily replicated in low-performing states."
The authors concluded that the results should reinforce the need for cooperation among the Health Care Financing Administration, beneficiaries, health plans, providers and practitioners to achieve improvements. PR
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.